|
|
|
The New York Academy of Sciences, New York
June 13 - 14, 2017
Strategies to stimulate neuroregeneration and neurorestoration hold promise to vastly improve the treatment of a range of neurological diseases and injuries, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), spinal cord injury, and multiple sclerosis (MS). While progress has been made in understanding the cellular mechanisms of these processes, more research is needed in order to translate this knowledge into more effective treatments that restore function to the central nervous system. This 2-day convening will bring together leading researchers, clinicians, industry, and governmental stakeholders from around the world to explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries. Plenary sessions will be designed to present emerging basic and clinical research in the following areas: neurodegenerative disease-modifying therapies that slow progression; mechanisms of neuroplasticity, including the role of dendritic spines, axonal growth, synaptic plasticity, inflammation, oxidative stress, mitochondrial function, and autophagy; glial function in the central nervous system; cutting-edge strategies to promote and modify neurogenesis; and biomarker and imaging modalities for neuroregeneration. The conference will conclude with an interactive panel discussion exploring future directions, critical open questions, and promising therapies in the field of neuroregeneration and neurorestoration.
|
|
|
|
|
|
Organized by:
|
|
The Myasthenia Gravis Foundation of America and the New York Academy of Sciences |
|
Invited Speakers:
|
|
Graham Collingridge, PhDUniversity of Toronto Ana Maria Cuervo, MD, PhDAlbert Einstein College of Medicine Valina Dawson, PhDJohns Hopkins School of Medicine Roman Giger, PhDUniversity of Michigan Steven Goldman, MD, PhDUniversity of Rochester Medical Center Gerd Kempermann, PhDDresden University of Technology and German Center for Neurodegenerative Diseases (DZNE) Arthur Konnerth, PhDTechnical University of Munich, Germany Jeffrey Macklis, MD, DHSTHarvard University Mark P. Mattson, PhDNational Institute on Aging, National Institutes of Health Guo-li Ming, MD, PhDJohns Hopkins School of Medicine Ralph A. Nixon, MD, PhDNew York University Langone Medical Center David Rowitch, MD, PhD, ScDUniversity of Cambridge and University of California, San Francisco Reisa A. Sperling, MD, MMScMassachusetts General Hospital James Surmeier, PhDNorthwestern University Clive Svendsen, PhDCedars-Sinai Medical Center
|
|
|
|
|
|
Deadline for Abstracts:
|
|
April 17, 2017
|
|
|
|
|
|
Registration:
|
|
Registration Pricing | By 05/01/2017 | After 05/01/2017 | Onsite | Member | $220 | $265 | $300 | Member (Student / Postdoc) | $115 | $145 | $190 | Nonmember (Academia) | $355 | $395 | $435 | Nonmember (Corporate) | $435 | $500 | $565 | Nonmember (Non-profit) | $355 | $395 | $435 | Nonmember (Student / Postdoc) | $170 | $200 | $245 |
Registration includes a complimentary, one-year membership to the New York Academy of Sciences. Complimentary memberships are provided to non-members only and cannot be used to renew or extend existing or expiring memberships. A welcome email will be sent upon registration which will include your membership credentials.
|
|
E-mail:
|
|
customerservice@nyas.org
|
|
|
|
|
|
|
|